Section of Odontology
Professor B E D Cooke spoke on clinical features associated with recurrent oral ulceration. The establishment of clinical criteria is important because the validity of laboratory findings depends upon an accurate clinical diagnosis of the conditions under scrutiny. From the all-embracing title of recurrent oral ulceration (ROU) is emerging a number of important groupings because oral ulceration is not so much a disease as a symptom. Wray et al. (1975) link ROU with deficiencies of vitamin B12, folic acid and iron; and link it with ulcerative colitis and cceliac disease. However, there is still a large group of patients who apart from their oral ulceration are fit, and who have no symptoms of any other disease process. The symptoms can range from the most trivial to the most incapacitating, when the patient has difficulty in speaking and eating, and life becomes an intolerable burden. Truelove & Morris-Owen (1958) coined the terms 'minor' and 'major' aphthous ulcers, to distinguish those ulcers which healed generally within fourteen days without scarring from those which lasted many weeks and resulted in deep scarring and sometimes loss of tissue. Patients present in the first or second decade, particularly if there are other members of the family affected. Acute exacerbations may occur from time to time, followed by long remissions which are quite unpredictable, but the ulceration becomes less severe and less frequent from the sixth decade onwards. Up to four ulcers may occur at one time and affect the nonkeratinized mucosa. The patient first feels a nodule and increased sensitivity in the area. The minor type presents as a localized hyperemia followed by a mucosal papule, then a necrotic ulcer with a marginal erythematous ring, and a gray membrane. The major type starts with a deep mucosal nodule with elevated margins and a diffuse erythema, and then extensive localized cedema with a crater-like ulcer, all of which ends with a scar.
Remissions occasionally occur in pregnancy and with the taking up of smoking. Both suggest that decreased keratinization may play a part in this disease, and Dolby (1968) found that with ROU in 20 female patients studied for ten months, the highest incidence was in the post-ovulation period when the degree of keratinization of the mucosa is low.
Trauma appears to be one of the major precipitating factors, and many of these patients have insufficient teeth with which to masticate their food. Nevertheless, the pattern of ulceration remains the same throughout the patient's life, and the minor form of aphthous ulceration does not develop into the major. A form of ROU, termed herpetiform ulceration by Cooke (1961) , distinguishes a group of herpeticlike lesions not actually caused by the herpes simplex virus. The ulceration begins as pin-head points, gradually enlarging and coalescing, and involving any part of the oral mucosa including the keratinized mucosa and sometimes the oral pharynx. In the patient's own words, 'they begin as dots which grow larger'. Females are predominantly affected, and they may suffer from almost continuous ulceration for a year or two at a time.
Herpetiform ulceration is relatively uncommon, and in a series reported by Lehner (1968) Lehner (1968) .
The prevalence of anamia was 2 % in the controls and 7 % in ROU. This increase was not statistically significant, suggesting that anemia does not play a primary xtiological role in ROU. However, significant increases were found in MjAU (14 %) and in HU (11 %). Consistently low serum iron values were found in over 500% of patients with MjAU, in 37 % of BS and in 22 % of HU, but no increased prevalence was found in MiAU in comparison with controls (7 %). Only 9/48 patients with low serum iron had concurrent anemia. The total iron binding capacity (TIBC) was normal or low in 14/16 patients with MjAU and low serum iron concentrations. This suggests that most of these patients do not have true iron deficiency, but that serum iron values are depressed as a result of the disease itself. This is commonly found in chronic diseases (Bainton & Finch 1964 , Fountain 1954 .
In ROU 4.4 % had folate deficiency (half with concurrent anamia) and this was not significantly greater than the 2 % of the controls. This agrees well with the 5.5 % found by Wray et al. (1975) .
Together these findings do not support the hypothesis that folate deficiency plays in etiological role in ROU.
The prevalence of B12 deficiency was the lowest of the factors examined and was found in 3/193 cases of ROU but in none of the controls. Pernicious anxemia was confirmed in these 3 patients. The low prevalence is in close agreement with the 4/130 cases of ROU reported by Wray et al. (1975) and suggests that vitamin B12 deficiency is unlikely to play a general role in ROU. The findings do not exclude the possibility that oral ulceration could be secondary to vitamin B12 or folate deficiency in some individual cases.
It was important to determine whether ROU associated with hematological abnormalities in this series could be distinguished from those without. Careful evaluation of the clinical history revealed that 9/10 patients with folate or vitamin B12 deficiency gave an atypical history. All 9 had either MiAU or HU clinically. The main distinguishing features were the short history, both in terms of total duration (less than two years) and in each episode of ulceration (2-5 days), and the presence in 8 of the patients of a depapillated tongue. Correction of the haematological abnormality resulted in complete cure in each case. Of the 9 cases of iron deficiency anxmia, 4 were considered to give an atypical history and all had MjAU clinically. The major points of differentiation were the late age of onset of ulceration (60 years+), the virtually continuous ulceration and the short total history (less than two years). All 4 patients responded to iron replacement therapy.
Of the total of 13 patients giving an atypical history, 10 had some other disease including cases of cceliac disease, epilepsy and partial gastrectomy.
ROU associated with hematological abnormalities and atypical histories is present in a small number of patients and could be distinguished from 'classical' ROU. It is suggested that this type of ROU is secondary to the hLmatological deficiency and should be termed 'pseudo-major', 'pseudo-minor' or 'pseudo-herpetiform' according to the clinical appearance (Challacombe et al. 1977) .
Dr M S Rose also discussed hmmatological features associated with ROU. Oral ulceration is well recognized amongst the clinical concomitants of megaloblastic anemias (Chanarin 1969 ). An editorial (British Medical Journal 1974) drew attention to the association between such anTmias and lesions resembling recurrent oral ulceration. As the vast majority of megaloblastic anLmias are caused by folic acid or vitamin B12 depletion, could oral ulceration be a manifestation of folate depletion in the absence of hmematological abnormality? In a survey of samples from 60 subjects who presented with oral mucosal disorder Rose (Rose, Tooze & Greenspan 1976, unpublished observations) identified levels of red cell folate beneath 200 gig/l in 27 (45 %). (It is worth emphasizing that serum levels of iron, folate, and B12 may fall to subnormal levels without representing depletion.) Of these, only 4 displayed megaloblastic features. Does this finding represent the cause of oral disorder or a nutritional consequence? Wray et al. (1975) employed red cell folate levels below 80 ig/l as a rather more stringent but nonetheless arbitrary determinant of folate depletion. Six out of their seven patients improved during folate administration. However, three were also receiving iron and one other was receiving B12-For the purist, etiological incrimination of folate depletion requires a rapid response to folate alone. Folate assays provide virtually uninterpretable data in the absence of changes in blood cell morphology. In patients with these changes, further investigation is indicated. Nonetheless only one of our four megaloblastic subjects responded to folate treatment. The gathering evidence (Rose, Tooze & Greenspan 1976, unpublished observations; Challacombe et al. 1977) suggests that low folate levels, either serum or red cell, are common in patients with longstanding oral mucosal symptoms, and that it is a consequence rather than a cause.
Dr S Ritchken reviewed the gut manifestations of recurrent oral ulceration. These are ill-defined, so it was decided to investigate such patients specifically looking for an association between ROU and cceliac disease.
Thirty unselected patients with ROU comprising 10 each with major, minor and herpetiform ulceration were investigated (Ritchken et al. 1977) . Each patient had blood screening tests for malnutrition, a barium follow-through and jejunal biopsy. Results revealed one patient to have an abnormal barium follow-through compatible with malabsorption, but with a normal jejunal biopsy; and one patient with partial villous atrophy but with normal radiology. The rest of the patients had normal radiology and biopsies. In 193 outpatients referred to the Department of Oral Immunology at Guy's Hospital, 4 (2.1 %) (Challacombe et al. 1977) had cceliac disease. This is a low prevalence compared with a recent investigation from Birmingham (Ferguson et al. 1976 ), in which 25 % (8 out of 33) of their patients with ROU were shown to have flat jejunal biopsies compatible with coeliac disease. In the patients with positive biopsy, the mouth ulcers improved on a gluten-free diet. The marked difference in the incidence of cceliac disease, between the present unselected group of 30 patients in whom only one showed some features compatible with cceliac disease and the Birmingham series of 25%, is difficult to interpret and might be due to epidemiological factors.
In a similar study of 10 patients with Behcet's disease, one was found to have cceliac disease, the remaining patients having no related intestinal symptoms, normal radiology and jejunal biopsies (Ritchken et al. 1977 ). This differs from Japanese studies (Oshima et al. 1963) , where 50% of such patients had minor intestinal symptoms, butjejunal biopsies in 15 patients failed to show atrophic villi (Asakura et al. 1973 ).
Professor T Lehner discussed immunological features associated with recurrent oral ulceration. Immunological investigation of ROU and Behcet's syndrome (BS) at centres in this country (Lehner 1964 , 1967 , Dolby 1969 , United States (Rogers et al. 1974 ) and Denmark (Donatsky 1976) have clearly shown that both cell-mediated and humoral immune responses are involved in the pathogenesis of these diseases. The immune responses have been largely studied with oral epithelial cells or homogenates, but cross-reacting microbial antigens are likely to be responsible for these reactions.
Hemagglutinating and fluorescent antibodies of the IgG and IgM classes seem to be present without any clinical correlation (Lehner 1969a ,b, Donatsky & Dabelsteen 1974 . In contrast the lymphoproliferative response, cytotoxicity and leukocyte migration inhibition have been correlated with the remitting nature of this type of ulceration (Lehner 1969b , Rogers et al. 1974 , Donatsby 1976 . The trigger responsible for switching on these cellular responses might be microbial, or a release from the suppressor activity of lymphocytes.
In the treatment of ROU topical corticosteroids and tetracycline have been used. A new approach has been recently introduced by administration of the immuno-potentiating drug levamisole (Lehner et al. 1976) . A double blind crossover trial of levamisole has been carried out in 47 patients with ROU. Significant decreases in the number ofulcers and ulcer days were found after two months of intermittent administration of levamisole. About 64% of patients responded to the drug by a decrease in the number of ulcers of more than 50 % for two or more months. The remaining 36 % of patients failed to respond to levamisole and 23 % of these had an increased number of ulcers. The side-effects recorded in patients taking levamisole were comparable with those in patients on placebo, except for a flu-like syndrome in one patient and urticaria in another, necessitating withdrawal of the drug. The mechanism of action of levamisole in ROU is not known, but it is suggested that levamisole may correct a deficiency of suppressor cells, or potentiate the cellular responses to crossreacting microbial agents.
